Literature DB >> 19459633

Location of inhibitors bound to group IVA phospholipase A2 determined by molecular dynamics and deuterium exchange mass spectrometry.

John E Burke1, Arneh Babakhani, Alemayehu A Gorfe, George Kokotos, Sheng Li, Virgil L Woods, J Andrew McCammon, Edward A Dennis.   

Abstract

An analysis of group IVA (GIVA) phospholipase A(2) (PLA(2)) inhibitor binding was conducted using a combination of deuterium exchange mass spectrometry (DXMS) and molecular dynamics (MD). Models of the GIVA PLA(2) inhibitors pyrrophenone and the 2-oxoamide AX007 docked into the protein were designed on the basis of deuterium exchange results, and extensive molecular dynamics simulations were run to determine protein-inhibitor contacts. The models show that both inhibitors interact with key residues that also exhibit changes in deuterium exchange upon inhibitor binding. Pyrrophenone is bound to the protein through numerous hydrophobic residues located distal from the active site, while the oxoamide is bound mainly through contacts near the active site. We also show differences in protein dynamics around the active site between the two inhibitor-bound complexes. This combination of computational and experimental methods is useful in defining more accurate inhibitor binding sites and can be used in the generation of better inhibitors against GIVA PLA(2).

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19459633      PMCID: PMC2762749          DOI: 10.1021/ja900098y

Source DB:  PubMed          Journal:  J Am Chem Soc        ISSN: 0002-7863            Impact factor:   15.419


  47 in total

1.  Structure-activity relationship of 2-oxoamide inhibition of group IVA cytosolic phospholipase A2 and group V secreted phospholipase A2.

Authors:  David A Six; Efrosini Barbayianni; Vassilios Loukas; Violetta Constantinou-Kokotou; Dimitra Hadjipavlou-Litina; Daren Stephens; Alan C Wong; Victoria Magrioti; Panagiota Moutevelis-Minakakis; Sharon F Baker; Edward A Dennis; George Kokotos
Journal:  J Med Chem       Date:  2007-08-02       Impact factor: 7.446

2.  Design and synthesis of 1-indol-1-yl-propan-2-ones as inhibitors of human cytosolic phospholipase A2alpha.

Authors:  Joachim Ludwig; Stefanie Bovens; Carsten Brauch; Alwine Schulze Elfringhoff; Matthias Lehr
Journal:  J Med Chem       Date:  2006-04-20       Impact factor: 7.446

3.  Discovery of Ecopladib, an indole inhibitor of cytosolic phospholipase A2alpha.

Authors:  Katherine L Lee; Megan A Foley; Lihren Chen; Mark L Behnke; Frank E Lovering; Steven J Kirincich; Weiheng Wang; Jaechul Shim; Steve Tam; Marina W H Shen; Soopeang Khor; Xin Xu; Debra G Goodwin; Manjunath K Ramarao; Cheryl Nickerson-Nutter; Frances Donahue; M Sherry Ku; James D Clark; John C McKew
Journal:  J Med Chem       Date:  2007-02-17       Impact factor: 7.446

4.  Design and synthesis of a novel and potent series of inhibitors of cytosolic phospholipase A(2) based on a 1,3-disubstituted propan-2-one skeleton.

Authors:  Stephen Connolly; Colin Bennion; Sarah Botterell; Pamela J Croshaw; Catherine Hallam; Kim Hardy; Paul Hartopp; Clive G Jackson; Sarah J King; Louise Lawrence; Antonio Mete; David Murray; David H Robinson; Gillian M Smith; Linda Stein; Iain Walters; Edward Wells; W John Withnall
Journal:  J Med Chem       Date:  2002-03-14       Impact factor: 7.446

Review 5.  Prostaglandins and leukotrienes: advances in eicosanoid biology.

Authors:  C D Funk
Journal:  Science       Date:  2001-11-30       Impact factor: 47.728

6.  Effects of pyrrophenone, an inhibitor of group IVA phospholipase A2, on eicosanoid and PAF biosynthesis in human neutrophils.

Authors:  N Flamand; S Picard; L Lemieux; M Pouliot; S G Bourgoin; P Borgeat
Journal:  Br J Pharmacol       Date:  2006-09-11       Impact factor: 8.739

7.  Arachidonyl trifluoromethyl ketone, a potent inhibitor of 85-kDa phospholipase A2, blocks production of arachidonate and 12-hydroxyeicosatetraenoic acid by calcium ionophore-challenged platelets.

Authors:  D Riendeau; J Guay; P K Weech; F Laliberté; J Yergey; C Li; S Desmarais; H Perrier; S Liu; D Nicoll-Griffith
Journal:  J Biol Chem       Date:  1994-06-03       Impact factor: 5.157

8.  Crystal structure of human cytosolic phospholipase A2 reveals a novel topology and catalytic mechanism.

Authors:  A Dessen; J Tang; H Schmidt; M Stahl; J D Clark; J Seehra; W S Somers
Journal:  Cell       Date:  1999-04-30       Impact factor: 41.582

9.  A phospholipid substrate molecule residing in the membrane surface mediates opening of the lid region in group IVA cytosolic phospholipase A2.

Authors:  John E Burke; Yuan-Hao Hsu; Raymond A Deems; Sheng Li; Virgil L Woods; Edward A Dennis
Journal:  J Biol Chem       Date:  2008-08-27       Impact factor: 5.157

10.  The interaction of phospholipase A2 with a phospholipid bilayer: coarse-grained molecular dynamics simulations.

Authors:  Chze Ling Wee; Kia Balali-Mood; David Gavaghan; Mark S P Sansom
Journal:  Biophys J       Date:  2008-05-09       Impact factor: 4.033

View more
  30 in total

Review 1.  Phospholipase A2 enzymes: physical structure, biological function, disease implication, chemical inhibition, and therapeutic intervention.

Authors:  Edward A Dennis; Jian Cao; Yuan-Hao Hsu; Victoria Magrioti; George Kokotos
Journal:  Chem Rev       Date:  2011-09-12       Impact factor: 60.622

Review 2.  Phospholipase A2 catalysis and lipid mediator lipidomics.

Authors:  Varnavas D Mouchlis; Edward A Dennis
Journal:  Biochim Biophys Acta Mol Cell Biol Lipids       Date:  2018-08-23       Impact factor: 4.698

Review 3.  Dynamic structural biology at the protein membrane interface.

Authors:  John E Burke
Journal:  J Biol Chem       Date:  2019-01-28       Impact factor: 5.157

4.  Analyses of Calcium-Independent Phospholipase A2beta (iPLA2β) in Biological Systems.

Authors:  S E Barbour; S Ramanadham
Journal:  Methods Enzymol       Date:  2016-10-18       Impact factor: 1.600

5.  Development of Potent and Selective Inhibitors for Group VIA Calcium-Independent Phospholipase A2 Guided by Molecular Dynamics and Structure-Activity Relationships.

Authors:  Varnavas D Mouchlis; Dimitris Limnios; Maroula G Kokotou; Efrosini Barbayianni; George Kokotos; J Andrew McCammon; Edward A Dennis
Journal:  J Med Chem       Date:  2016-04-28       Impact factor: 7.446

6.  Computer-aided drug design guided by hydrogen/deuterium exchange mass spectrometry: A powerful combination for the development of potent and selective inhibitors of Group VIA calcium-independent phospholipase A2.

Authors:  Varnavas D Mouchlis; Christophe Morisseau; Bruce D Hammock; Sheng Li; J Andrew McCammon; Edward A Dennis
Journal:  Bioorg Med Chem       Date:  2016-05-10       Impact factor: 3.641

7.  Potent and selective fluoroketone inhibitors of group VIA calcium-independent phospholipase A2.

Authors:  George Kokotos; Yuan-Hao Hsu; John E Burke; Constantinos Baskakis; Christoforos G Kokotos; Victoria Magrioti; Edward A Dennis
Journal:  J Med Chem       Date:  2010-05-13       Impact factor: 7.446

8.  Membranes serve as allosteric activators of phospholipase A2, enabling it to extract, bind, and hydrolyze phospholipid substrates.

Authors:  Varnavas D Mouchlis; Denis Bucher; J Andrew McCammon; Edward A Dennis
Journal:  Proc Natl Acad Sci U S A       Date:  2015-01-26       Impact factor: 11.205

9.  Discovery of a novel series of inhibitors of lymphoid tyrosine phosphatase with activity in human T cells.

Authors:  Stephanie M Stanford; Divya Krishnamurthy; Matthew D Falk; Rossella Messina; Bikash Debnath; Sheng Li; Tong Liu; Roza Kazemi; Russell Dahl; Yantao He; Xiao Yu; Andrew C Chan; Zhong-Yin Zhang; Amy M Barrios; Virgil L Woods; Nouri Neamati; Nunzio Bottini
Journal:  J Med Chem       Date:  2011-02-22       Impact factor: 7.446

Review 10.  Using hydrogen/deuterium exchange mass spectrometry to define the specific interactions of the phospholipase A2 superfamily with lipid substrates, inhibitors, and membranes.

Authors:  Jian Cao; John E Burke; Edward A Dennis
Journal:  J Biol Chem       Date:  2012-12-03       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.